Exclusive enteral nutrition and induction of remission of active Crohn's disease in children

Expert Review of Clinical Immunology

Volumn 9, Issue 4, 2013, Pages 375-384

  Day, Andrew S ^a   Burgess, Laura ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

children; Crohn's disease; exclusive enteral nutrition; mechanisms; nutrition; outcomes

Indexed keywords

AMINOTRANSFERASE; CALGRANULIN; CORTICOSTEROID; CYANOCOBALAMIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; SELENIUM; TUMOR NECROSIS FACTOR ALPHA; ZINC;

AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ANTIINFLAMMATORY ACTIVITY; CHILD; CLINICAL PROTOCOL; CONSTIPATION; CROHN DISEASE; DIARRHEA; DIET THERAPY; DIETARY INTAKE; ELEMENTAL DIET; ENTERIC FEEDING; HUMAN; IRON DEFICIENCY; MEMBRANE PERMEABILITY; NASOGASTRIC TUBE; NAUSEA; NUTRITIONAL DEFICIENCY; PATHOGENESIS; PATIENT ATTITUDE; REFEEDING SYNDROME; REMISSION; REVIEW; TIGHT JUNCTION; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; AGE OF ONSET; CHILD; CROHN DISEASE; ENTERAL NUTRITION; FOOD HABITS; GENE-ENVIRONMENT INTERACTION; HUMANS; REMISSION INDUCTION;

EID: 84875933273     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.13.12     Document Type: Review

References (55)

1. Griffiths AM, Hugot J-P. Crohn disease (Chapter 41). Pediatric Gastrointestinal Disease (4th Edition). Walker A, Goulet O, Kleinman RE et al. (Eds). BC Decker, Hamilton, Ontario, Canada (2004
2. Rogers BH, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: An analysis of a computerized file of 1400 patients. J. Chronic Dis. 24(12), 743-773 (1971
3. Day AS, Ledder O, Leach ST, Lemberg DA. Crohn's and colitis in children and adolescents. World J. Gastroenterol. 18(41), 5862-5869 (2012
4. Day AS, Whitten KE, Sidler M, Lemberg DA. Systematic review: Nutritional therapy in paediatric Crohn's disease. Aliment. Pharmacol. Ther. 27(4), 293-307 (2008
5. Van Limbergen J, Russell RK, Drummond HE et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135(4), 1114-1122 (2008
6. Dotson JL, Hyams JS, Markowitz J et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J. Pediatr. Gastroenterol. Nutr. 51(2), 140-145 (2010
7. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: Recommendations for diagnosis - The Porto criteria. J. Pediatr. Gastroenterol. Nutr. 41, 1-7 (2005
8. Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease. Nat. Rev. Gastroenterol. Hepatol. 6(9), 513-523 (2009
9. Levin AD, Wadhera V, Leach ST et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig. Dis. Sci. 56(3), 830-836 (2011
10. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38(4), 543-548 (1996
11. Verma S, Kirkwood B, Brown S, Giaffer MH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig. Liver Dis. 32(9), 769-774 (2000
12. Harries AD, Jones LA, Danis V et al. Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet 1(8330), 887-890 (1983
13. Whitten KE, Rogers P, Ooi CY, Day AS. International survey of enteral nutrition protocols used in children with Crohn's disease. J. Dig. Dis. 13(2), 107-112 (2012
14. Day AS, Whitten KE, Lemberg DA et al. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: A feasible and effective approach. J. Gastroenterol. Hepatol. 21(10), 1609-1614 (2006
15. Critch J, Day AS, Otley AR et al. Clinical report: The utilization of enteral nutrition for the control of intestinal inflammation in pediatric crohn disease. J. Pediatr. Gastroenterol. Nutr. 54, 298-305 (2012
16. Buchanan E, Gaunt WW, Cardigan T, Garrick V, McGrogan P, Russell RK. The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Aliment. Pharmacol. Ther. 30(5), 501-507 (2009
17. Gerasimidis K, Nikolaou CK, Edwards CA, McGrogan P. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: Associations with disease activity, treatment response, and prediction of a clinical relapse. J. Clin. Gastroenterol. 45(3), 234-239 (2011
18. Lambert B, Lemberg DA, Leach ST, Day AS. Longer-term outcomes of nutritional management of Crohn's disease in children. Dig. Dis. Sci. 57(8), 2171-2177 (2012
19. Knight C, El-Matary W, Spray C, Sandhu BK. Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin. Nutr. 24(5), 775-779 (2005
20. Berni Canani R, Terrin G, Borrelli O et al. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig. Liver Dis. 38(6), 381-387 (2006
21. Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: A randomised controlled trial. Gut 55(3), 356-361 (2006
22. Gupta K, Noble A, Baldassano R, Sreedharan R, Grossman A, Kachelries K. A novel enteral nutritional therapy protocol for the treatment of pediatric Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 51(Suppl. 2), E87 (2010
23. Rubio A, Pigneur B, Garnier-Lengliné H et al. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment. Pharmacol. Ther. 33(12), 1332-1339 (2011
24. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J. Pediatr. Gastroenterol. Nutr. 31(1), 8-15 (2000
25. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst. Rev. 1, CD000542 (2007
26. Afzal NA, Davies S, Paintin M et al. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig. Dis. Sci. 50(8), 1471-1475 (2005
27. Wong S, Lemberg DA, Day AS. Exclusive enteral nutrition in the management of perianal Crohn's disease in children. J. Dig. Dis. 11(3), 185-188 (2010
28. Borrelli O, Cordischi L, Cirulli M et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: A randomized controlled open-label trial. Clin. Gastroenterol. Hepatol. 4(6), 744-753 (2006
29. Fell JM, Paintin M, Arnaud-Battandier F et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment. Pharmacol. Ther. 14(3), 281-289 (2000
30. Whitten KE, Leach ST, Bohane TD, Woodhead HJ, Day AS. Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease. J. Gastroenterol. 45(4), 399-405 (2010
31. Schatorjé E, Hoekstra H. Transient hypertransaminasemia in paediatric patients with Crohn disease undergoing initial treatment with enteral nutrition. J. Pediatr. Gastroenterol. Nutr. 51(3), 336-340 (2010
32. Lemberg DA, Leach ST, Day AS. Transient hypertransaminasemia in pediatric patients with Crohn disease. J. Pediatr. Gastroenterol. Nutr. 53(2), 229 (2011
33. Afzal NA, Addai S, Fagbemi A, Murch S, Thomson M, Heuschkel R. Refeeding syndrome with enteral nutrition in children: A case report, literature review and clinical guidelines. Clin. Nutr. 21(6), 515-520 (2002
34. Akobeng AK, Thomas AG. Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease. J. Pediatr. Gastroenterol. Nutr. 51(3), 364-366 (2010
35. Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, Mitchell H. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm. Bowel Dis. 16
36. Man SM, Zhang L, Day AS, Leach S, Mitchell H. Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter 13
37. Kaakoush NO, Deshpande NP, Wilkins MR et al. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS ONE 6
38. Pryce-Millar E, Murch SH, Heuschkel RB. Enteral nutrition therapy in Crohn's disease changes the mucosal flora. J. Pediatr. Gastroenterol. Nutr. 39(Suppl. 1), 289 (2009
39. Lionetti P, Callegari ML, Ferrari S et al. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J. Parenter. Enteral Nutr. 29(Suppl. 4), S175-S178 (2005
40. Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease. Aliment. Pharmacol. Ther. 28(6), 724-733 (2008
41. Shiga H, Kajiura T, Shinozaki J et al. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig. Liver Dis. 44(9), 736-742 (2012
42. Kajiura T, Takeda T, Sakata S et al. Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis. Dig. Dis. Sci. 54(9), 1892-1900 (2009
43. Gerasimidis K, McGrogan P, Garrick V, Hassan K, Edwards CA. Effect of exclusive enteral nutrition on colonic bacterial activity in paediatric Crohn's disease. Proceed. Nutr. Soc. 67, E425 (2008
44. Tjellström B, Högberg L, Stenhammar L et al. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand. J. Gastroenterol. 47(12), 1454-1459 (2012
45. Whelan K, Judd PA, Tuohy KM, Gibson GR, Preedy VR, Taylor MA. Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am. J. Clin. Nutr. 89(1), 240-247 (2009
46. Schneider SM, Girard-Pipau F, Anty R et al. Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota. Clin. Nutr. 25(1), 82-90 (2006
47. Day AS, Keenan J, Tyrer P. Nutritional influences upon CEACAM6 expression by intestinal epithelial cells. Gastroenterology 142(Suppl. 1), S376 (2012
48. de Jong NS, Leach ST, Day AS. Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig. Dis. Sci. 52(9), 2029-2036 (2007
49. Förster C. Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 130(1), 55-70 (2008
50. Weber CR, Turner Jr Inflammatory bowel disease: Is it really just another break in the wall? Gut 56(1), 6-8 (2007
51. Nahidi L, Day AS, Lemberg DA, Leach ST. Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model. J. Gastroenterol. 47(2), 107-117 (2012
52. Levine A, Milo T, Buller H, Markowitz J. Consensus and controversy in the management of pediatric Crohn disease: An international survey. J. Pediatr. Gastroenterol. Nutr. 36(4), 464-469 (2003
53. Gråfors JM, Casswall TH. Exclusive enteral nutrition in the treatment of children with Crohn's disease in Sweden: A questionnaire survey. Acta Paediatr. 100(7), 1018-1022 (2011
54. Day AS, Stephenson T, Stewart M, Otley AR. Exclusive enteral nutrition for children with Crohn's disease: Use in Australia and attitudes of Australian paediatric gastroenterologists. J. Paediatr. Child Health 45(6), 337-341 (2009
55. Stewart M, Day AS, Otley A. Physician attitudes and practices of enteral nutrition as primary treatment of paediatric Crohn disease in North America. J. Pediatr. Gastroenterol. Nutr. 52(1), 38-42 (2011